Literature DB >> 15096363

Potentially fatal interaction between diltiazem and statins.

Patrick Gladding, Helen Pilmore, Colin Edwards.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15096363     DOI: 10.7326/0003-4819-140-8-200404200-00037-w1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

2.  Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report.

Authors:  Stephen I Rifkin
Journal:  Medscape J Med       Date:  2008-11-19

3.  Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions.

Authors:  Richard Boyce; Carol Collins; John Horn; Ira Kalet
Journal:  J Biomed Inform       Date:  2009-06-16       Impact factor: 6.317

Review 4.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

5.  The influence of high-dose simvastatin and diltiazem on myocardium in rabbits: a haemodynamic study.

Authors:  Magdalena Jasińska; Jacek Owczarek; Daria Orszulak-Michalak
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

6.  Noncardiogenic Pulmonary Edema after Amlodipine Overdose without Refractory Hypotension and Bradycardia.

Authors:  M Hedaiaty; N Eizadi-Mood; A M Sabzghabaee
Journal:  Case Rep Emerg Med       Date:  2015-05-05

7.  Potential statin-drug interactions: prevalence and clinical significance.

Authors:  Maria Zhelyazkova-Savova; Silvia Gancheva; Vera Sirakova
Journal:  Springerplus       Date:  2014-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.